FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3019707556> ?p ?o ?g. }

• W3019707556 endingPage "108005" @default.
• W3019707556 startingPage "108005" @default.
• W3019707556 abstract "Although previous studies have shown that opioid agonist therapy (OAT) is linked to reductions in illicit opioid use, less is known about how OAT impacts the use of other psychoactive substances. We aimed to examine the changes in use of different substances by comparing patterns before and after initiating OAT. Data for this study was derived from three ongoing prospective cohorts involving people who use drugs in Vancouver, Canada from 1996 to 2018. We assessed use patterns for heroin, illicit prescription opioid, cocaine, crack cocaine, crystal methamphetamine, cannabis, daily alcohol use, and benzodiazepines. Segmented regression was conducted to compare the trends of substance use between pre-treatment and post-treatment periods. The study included 1107 participants. After OAT engagement, we observed an immediate decline in the proportion as well as a decreasing trend for heroin (Adjusted Odds Ratio (AOR): 0.80, 95% confidence interval (CI): 0.77, 0.83), illicit prescription opioid (AOR: 0.87, 95% CI: 0.83, 0.90), and benzodiazepines (AOR: 0.73, 95 % CI: 0.67, 0.80). There was no significant difference comparing the pre-treatment and post-treatment trends for cocaine, crack cocaine, crystal methamphetamine, and cannabis. However, higher growth slope was noted during the post-treatment period for daily alcohol use (P = 0.016). We observed significant reduction in illicit opioids use following OAT initiation, but not for stimulant and cannabis. The increasing problematic use of alcohol may pose challenges to the safety and effectiveness of OAT. Development of comprehensive and tailored treatment strategies is needed for poly-substance users accessing OAT." @default.
• W3019707556 created "2020-05-01" @default.
• W3019707556 creator A5015210332 @default.
• W3019707556 creator A5023506411 @default.
• W3019707556 creator A5029471416 @default.
• W3019707556 creator A5030246925 @default.
• W3019707556 creator A5061043962 @default.
• W3019707556 creator A5073679067 @default.
• W3019707556 creator A5079981787 @default.
• W3019707556 creator A5091881218 @default.
• W3019707556 date "2020-07-01" @default.
• W3019707556 modified "2023-10-13" @default.
• W3019707556 title "Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting" @default.
• W3019707556 cites W1945601059 @default.
• W3019707556 cites W1958535246 @default.
• W3019707556 cites W1963784393 @default.
• W3019707556 cites W1967132158 @default.
• W3019707556 cites W1974264597 @default.
• W3019707556 cites W1984986783 @default.
• W3019707556 cites W1985447886 @default.
• W3019707556 cites W1991565490 @default.
• W3019707556 cites W1999598656 @default.
• W3019707556 cites W2000815662 @default.
• W3019707556 cites W2007149475 @default.
• W3019707556 cites W2021847155 @default.
• W3019707556 cites W2034509002 @default.
• W3019707556 cites W2048849975 @default.
• W3019707556 cites W2049569412 @default.
• W3019707556 cites W2051366813 @default.
• W3019707556 cites W2059935553 @default.
• W3019707556 cites W2060726569 @default.
• W3019707556 cites W2105534262 @default.
• W3019707556 cites W2112963881 @default.
• W3019707556 cites W2141315447 @default.
• W3019707556 cites W2150115621 @default.
• W3019707556 cites W2152480297 @default.
• W3019707556 cites W2160427818 @default.
• W3019707556 cites W2161958405 @default.
• W3019707556 cites W2171468146 @default.
• W3019707556 cites W2315631840 @default.
• W3019707556 cites W2319647004 @default.
• W3019707556 cites W2346844050 @default.
• W3019707556 cites W2496974376 @default.
• W3019707556 cites W2592101686 @default.
• W3019707556 cites W2728628377 @default.
• W3019707556 cites W2729557480 @default.
• W3019707556 cites W2735772421 @default.
• W3019707556 cites W2749496257 @default.
• W3019707556 cites W2752541850 @default.
• W3019707556 cites W2753609137 @default.
• W3019707556 cites W2753748213 @default.
• W3019707556 cites W2756770489 @default.
• W3019707556 cites W2758150071 @default.
• W3019707556 cites W2762254212 @default.
• W3019707556 cites W2803704518 @default.
• W3019707556 cites W2892255554 @default.
• W3019707556 cites W2902655755 @default.
• W3019707556 cites W2903023530 @default.
• W3019707556 cites W4375906107 @default.
• W3019707556 doi "https://doi.org/10.1016/j.drugalcdep.2020.108005" @default.
• W3019707556 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7462099" @default.
• W3019707556 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32370932" @default.
• W3019707556 hasPublicationYear "2020" @default.
• W3019707556 type Work @default.
• W3019707556 sameAs 3019707556 @default.
• W3019707556 citedByCount "19" @default.
• W3019707556 countsByYear W30197075562020 @default.
• W3019707556 countsByYear W30197075562021 @default.
• W3019707556 countsByYear W30197075562022 @default.
• W3019707556 countsByYear W30197075562023 @default.
• W3019707556 crossrefType "journal-article" @default.
• W3019707556 hasAuthorship W3019707556A5015210332 @default.
• W3019707556 hasAuthorship W3019707556A5023506411 @default.
• W3019707556 hasAuthorship W3019707556A5029471416 @default.
• W3019707556 hasAuthorship W3019707556A5030246925 @default.
• W3019707556 hasAuthorship W3019707556A5061043962 @default.
• W3019707556 hasAuthorship W3019707556A5073679067 @default.
• W3019707556 hasAuthorship W3019707556A5079981787 @default.
• W3019707556 hasAuthorship W3019707556A5091881218 @default.
• W3019707556 hasBestOaLocation W30197075562 @default.
• W3019707556 hasConcept C118552586 @default.
• W3019707556 hasConcept C126322002 @default.
• W3019707556 hasConcept C156957248 @default.
• W3019707556 hasConcept C170493617 @default.
• W3019707556 hasConcept C2426938 @default.
• W3019707556 hasConcept C2777056318 @default.
• W3019707556 hasConcept C2778903686 @default.
• W3019707556 hasConcept C2779418921 @default.
• W3019707556 hasConcept C2780035454 @default.
• W3019707556 hasConcept C2780376393 @default.
• W3019707556 hasConcept C2780557958 @default.
• W3019707556 hasConcept C2781063702 @default.
• W3019707556 hasConcept C44249647 @default.
• W3019707556 hasConcept C48856860 @default.
• W3019707556 hasConcept C71924100 @default.
• W3019707556 hasConcept C98274493 @default.
• W3019707556 hasConceptScore W3019707556C118552586 @default.
• W3019707556 hasConceptScore W3019707556C126322002 @default.

• next